abstract |
The present disclosure provides pharmaceutical compositions for treating age-related macular degeneration (AMD) in a subject by intravitreally administering a pharmaceutical composition adapted for gene therapy, comprising a vector having a nucleic acid sequence encoding aflibercept, and Provides a way. |